Robot arm targets tumours

A robotic arm armed wielding high-intensity radiation that can target tumours which move with breathing has proven effective in treating lung cancer.

In trials, medical physicist Cihat Ozhasoglu of the University of Pittsburgh Medical Center has managed to eradicate tumours in some patients after 3-4 months of treatment using the arm. Although it is too early to determine the technique's long-term effectiveness, Ozhasoglu and his colleagues believe the new approach holds promise for the future treatment of lung cancer and other tumours that move during breathing.

Ozhasoglu heads a team working with the CyberKnife, a radiation delivery system manufactured by Accuray, that uses a precise robotic arm designed to aim highly focused X-ray beams at the site of a tumour. There are currently 76 active CyberKnife sites worldwide, and an additional 62 scheduled to be installed globally.

Recently, the Pittsburgh researchers upgraded their CyberKnife by adding a system called "Synchrony," which accurately targets tumours that move as a result of breathing. Synchrony instructs the robotic arm to move the radiation source, a linear accelerator that produces X-rays, in synchronisation with the tumour motion.

Register now to continue reading

Thanks for visiting The Engineer. You’ve now reached your monthly limit of news stories. Register for free to unlock unlimited access to all of our news coverage, as well as premium content including opinion, in-depth features and special reports.  

Benefits of registering

  • In-depth insights and coverage of key emerging trends

  • Unrestricted access to special reports throughout the year

  • Daily technology news delivered straight to your inbox